Botulinum toxin: The Newport Beach experience

Dermatologic Surgery

Volumn 24, Issue 11, 1998, Pages 1219-1224

  Fulton, James E ^a  

^a Fulton Skin Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BOTULINUM TOXIN A; IBUPROFEN; SALICYLIC ACID;

ARTICLE; DRUG EFFICACY; DRUG POTENCY; FACE MUSCLE; FACE SURGERY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TREATMENT INDICATION;

EID: 0031753027     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4725.1998.tb04101.x     Document Type: Article

References (8)

1. Carruthers J, Carruthers A. Treatment of glabellae frown lines with C. botulinum. Dermatol Surg 1992;18:17-21.
2. Blitzer A, Brin MR, et al. Botulinum for the treatment of hyperfunctional lines of the face. Arch Otolarynal 1993;119:1018-22.
3. Garcia A, Fulton JE. Cosmetic denervation of the muscles of facial expression with Botulinum toxin: a dose response study. J. Dermatol Surg Oncol 1996;22:39-43.
4. Hartman JP. Second batch of Botox may be more potent than the first. Skin Allergy News 1998;29:1-7.
5. Klein A. A method of botulinum toxin injection. Presented at Botulinum Toxin A-Z. Newport Beach, Virginia, 1997.
6. Guiyra JG, Huddleston SW. Aesthetic indications for botulinum toxin injection. Plast Reconstr Surg 1994;93:913-8.
7. Barodek G, Pearce B, Johnson E. Antibodies to botulinum toxin. Ophthalmology 1994;101:1158-62.
8. Borodic G, Johnson E, Goodnough M, Schantz F. Botulinum toxin therapy, immunologic resistance and problems with available materials. Neurology 1996;46:26-9.